Benjamin L. Kagan

发表

Tyrosine Phosphorylation of the Nuclear Receptor Coactivator AIB1/SRC-3 Is Enhanced by Abl Kinase and Is Required for Its Activity in Cancer Cells

Sivanesan Dakshanamurthy, Anton Wellstein, John T. Lahusen, 2008, Molecular and Cellular Biology.

Proteomic Analysis of Pathways Involved in Estrogen-Induced Growth and Apoptosis of Breast Cancer Cells

Cathy H. Wu, Zhang-Zhi Hu, A. Wellstein, 2011, PloS one.

Serum induction of the fibroblast growth factor-binding protein (FGF-BP) is mediated through ERK and p38 MAP kinase activation and C/EBP-regulated transcription

A. Wellstein, C. Coticchia, A. Riegel, 2001, Oncogene.

Growth Factor Regulation of an Angiogenic Factor, the Fibroblast Growth Factor-Binding Protein (FGF-BP), in Breast Cancer

Benjamin L. Kagan, 2002 .

Modulation of transcription parameters in glucocorticoid receptor-mediated repression

S. Simons, Benjamin L. Kagan, Yunguang Sun, 2008, Molecular and Cellular Endocrinology.

Theory of partial agonist activity of steroid hormones

C. Chow, S. Simons, Benjamin L. Kagan, 2015, AIMS molecular science.

A theoretical framework for gene induction and experimental comparisons

Carson C. Chow, S. Simons, Benjamin L. Kagan, 2010, Proceedings of the National Academy of Sciences.

Induction of the Angiogenic Modulator Fibroblast Growth Factor-binding Protein by Epidermal Growth Factor Is Mediated through Both MEK/ERK and p38 Signal Transduction Pathways*

A. Wellstein, C. Coticchia, A. Riegel, 2000, The Journal of Biological Chemistry.

The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer

A. Wellstein, A. Riegel, T. Lahusen, 2009, Breast Cancer Research and Treatment.

Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.

Sehyung Cho, S. Simons, Benjamin L. Kagan, 2005, Molecular endocrinology.

Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.

A. Wellstein, A. Riegel, R. Cabal-Manzano, 2003, Cancer research.